GlassScriptPhysician profile
Randall Wood
NPI 1477245488
$734.38
in general payments reported to CMS, 2019-2025
11 companies · $57.73 in 2025
The $57.73 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $264 · 2024: $413 · 2025: $57.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $734.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $124.99 | 2023 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $124.49 | 2023 | Nuzyra |
| Kerecis Limited | $124.22 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Orthofix Medical, INC. | $118.95 | 2024 | Physio-Stim |
| Nevro Corp. | $99.99 | 2024 | Senza |
| Abbvie INC. | $40.49 | 2024 | |
| Polynovo North America LLC | $29.08 | 2024 | Novosorb Btm |
| Stryker Corporation | $21.27 | 2025 | Citrefix |
| Vertex Pharmaceuticals Incorporated | $18.28 | 2025 | |
| Nexus Medical Technologies LLC | $18.18 | 2025 | |
| Rock Medical Orthopedics, INC. | $14.44 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Wood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.